Costs of schizophrenia

被引:142
作者
Knapp, M [1 ]
机构
[1] Inst Psychiat, London SE5 8AF, England
[2] London Sch Econ, London, England
关键词
SERIOUS MENTAL-ILLNESS; RANDOMIZED CONTROLLED TRIAL; ACUTE PSYCHIATRIC-SERVICES; PROSPECTIVE FOLLOW-UP; HOSPITAL-BASED CARE; HEALTH-CARE; CLOZAPINES COST; ECONOMIC COSTS; RESISTANT SCHIZOPHRENIA; PSYCHOTIC-PATIENTS;
D O I
10.1192/bjp.171.6.509
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background Schizophrenia is a common and burdensome illness, with implications not only for the health service but for a host of other care agencies - public and private - as well as for patients, families and the wider society. Method The paper reviews available UK evidence on the cost of schizophrenia (broadly defined) and on the cost-effectiveness of treatment options and alternative care arrangements. New evidence potentially alters our view of the costs of this illness. Results Aggregating the identifiable direct and indirect costs of schizophrenia for England suggests an annual cost of pound 2.6 billion, but even this sum omits some indirect impacts which cannot currently be costed, Just over half the identified total is accounted for by the direct costs falling to the NHS, local authorities, charities and the criminal justice system, in helping to tackle this cost burden, there is now a body of evidence on cost-effective community care arrangements, antipsychotic drugs and psychological interventions. Conclusions Although the costs of schizophrenia are considerable, there are treatments and care arrangements which can reduce this aggregate burden while maintaining or improving effectiveness.
引用
收藏
页码:509 / 518
页数:14
相关论文
共 117 条
[1]  
ADDINGTON DE, 1993, CLIN THER, V15, P917
[2]   Cost-effectiveness of clozapine - A UK clinic-based study [J].
Aitchison, KJ ;
Kerwin, RW .
BRITISH JOURNAL OF PSYCHIATRY, 1997, 171 :125-130
[3]   Reduction of healthcare resource utilisation and costs following the use of risperidone for patients with schizophrenia previously treated with standard antipsychotic therapy - A retrospective analysis using the Saskatchewan Health Linkable Databases [J].
Albright, PS ;
Livingstone, S ;
Keegan, DL ;
Ingham, M ;
Shrikhande, S ;
LeLorier, J .
CLINICAL DRUG INVESTIGATION, 1996, 11 (05) :289-299
[4]   SCHIZOPHRENIA - A LIFE-SHORTENING DISEASE [J].
ALLEBECK, P .
SCHIZOPHRENIA BULLETIN, 1989, 15 (01) :81-89
[5]  
Anderson C., 1991, British Journal of Psychiatry, V159, P30
[6]  
ANDREWS G, 1985, ARCH GEN PSYCHIAT, V42, P537
[7]  
*AT HLTH SERV EX, 1996, BURD DIS
[8]   HOME-BASED VERSUS OUTPATIENT INPATIENT CARE FOR PEOPLE WITH SERIOUS MENTAL-ILLNESS - PHASE-II OF A CONTROLLED-STUDY [J].
AUDINI, B ;
MARKS, IM ;
LAWRENCE, RE ;
CONNOLLY, J ;
WATTS, V .
BRITISH JOURNAL OF PSYCHIATRY, 1994, 165 :204-210
[9]  
Beecham J., 1997, Care in the community: Illusion or reality?, P93
[10]  
BEECHAM JK, 1995, EC EVALUATION MENTAL, P175